A major complication of advanced prostate cancer is malignant obstructive uropathy, a condition that can precipitate post-renal acute kidney injury and ultimately require hemodialysis intervention. We present a striking imaging example of a patient with metastatic castration-resistant prostate cancer (mCRPC) and dialysis-dependent renal failure who demonstrated marked tumor regression and discontinuation of dialysis following 177 Lu-PSMA radioligand therapy.
9 July 2026 in Nuclear Medicine and Molecular Imaging
Background/Objectives: Cytologically indeterminate thyroid nodules (Bethesda III–IV) remain a diagnostic challenge. We evaluated the TRAICK (version 1.9.4; TRAICK, Istanbul, Türkiye) artificial intelligence (AI) system, which generates an American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) category and an imaging-derived Bethesda-like risk category from gray-scale ultrasound images. Methods: This retrospective proof-of-concept study included 52 surgically resected nodules with Bethesda III (n = 29) or IV (n = 23) cytology, with histopathology of the index nodule as the reference standard. The two TRAICK outputs were analyzed separately, and the ACR TI-RADS output was compared with two radiologists using the McNemar and DeLong tests. Results: Twenty-three nodules (44.2%) were malignant on index-nodule histopathology. The TRAICK ACR TI-RADS output had an accuracy of 71.2% (95% CI 57.7–81.7) and an area under the ROC curve (AUC) of 0.762 (0.640–0.884). Its AUC did not differ significantly from that of Radiologist 1 (0.762 vs. 0.777, p = 0.783); specificity was higher (65.5% vs. 37.9%, p = 0.021), whereas sensitivity was lower without a statistically significant difference (78.3% vs. 91.3%, p = 0.250). Compared with Radiologist 2, the TRAICK ACR TI-RADS output had higher accuracy (71.2% vs. 51.9%, p = 0.013), specificity (65.5% vs. 24.1%, p < 0.001), and AUC (0.762 vs. 0.629, p = 0.042). The Bethesda-like output had an AUC of 0.822 (0.707–0.938), with a sensitivity of 60.9% and specificity of 86.2% at the V–VI threshold. In sensitivity analyses, the AUC of the ACR TI-RADS output did not differ significantly from that of Radiologist 1, whereas its AUC advantage over Radiologist 2 was not statistically significant when low-risk neoplasms were classified as malignant. Conclusions: In this small, selected surgical cohort, the TRAICK ACR TI-RADS output showed discrimination that did not differ significantly from that of the more accurate of two experienced radiologists, with higher specificity, and its Bethesda-like output showed promising discrimination. These findings support further study of TRAICK as a complementary aid for preoperative decision-making; independent prospective validation is needed.
We report a 77-year-old woman with papillary renal cell carcinoma showing no increased [ 68 Ga]Ga-FAPI uptake in the primary tumor, while intense sacral FAPI uptake mimicked bone metastasis. MRI findings and 2-year follow-up supported a sacral insufficiency fracture without metastatic disease. This case highlights fracture-related FAPI uptake as an important oncologic imaging pitfall.
We report a rare case of multifocal hepatic epithelioid hemangioendothelioma (HEHE) evaluated using [⁶⁸Ga]Ga-FAPI-04 and [¹⁸F]FDG PET/CT. Abdominal CT revealed multiple hepatic masses with mild peripheral enhancement and central necrosis. On [¹⁸F]FDG PET/CT, the lesions demonstrated uptake similar to or faint compared with normal liver parenchyma, whereas [⁶⁸Ga]Ga-FAPI-04 PET/CT showed intense tracer accumulation with a high tumor-to-background ratio in all hepatic lesions, without evidence of extrahepatic involvement. This case illustrates the potential diagnostic advantage of FAPI imaging in detecting and characterizing hepatic vascular tumors with low FDG avidity.